Follow us on
Search News Archives
Conferences | Events
Lab Bulletin Media Partners
FluidiGM Europe

FluidiGM Europe

FluidiGM Europe

Products

Contact FluidiGM Europe


If you have not logged into the website then please enter your details below.

All articles from FluidiGM Europe

  Fluidigm to Develop and Supply a Custom High-Throughput Prep System for HLA Typing

Custom system will ultimately enable DKMS Life Science Lab to type several thousand samples per week

Access Array System from FluidiGMFluidigm announced an agreement to develop and supply a customized version of its high- throughput library prep system to the DKMS (Deutsche Knochenmarkspenderdatei gemeinnützige Gesellschaft mbH) Life Science Lab. The new system will help the DKMS accelerate its research to fight against blood cancer by ultimately enabling it to characterize the HLA genes from several thousand samples a week for its donor registry...

 

  Singapore Single-Cell Research Centre Opens Door for Asian Biological Discoveries

Centre Dedicated to Diagnosis and Treatment Derived from Single-Cell Exploration

Fluidigm logoGovernment officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore on April 12, 2013. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells....

 

  Fluidigm Announces Unrestricted Sales into Prenatal Health and Non-Invasive Prenatal Diagnostics Fields of Research Fluidigm Corporation has announced that it can now offer unrestricted sales of its digital PCR and other advanced technology to customers interested in pursuing research and product development into the prenatal health and non-invasive prenatal diagnostics fields,

FluidigmThis enhanced freedom to operate comes as a result of the ending of the collaboration agreement previously reported in the company's filings with the Securities and Exchange Commission between Fluidigm and Novartis Vaccines & Diagnostics, Inc...

 

  New Research Center to Focus on Mammalian Single Cell Genomics The Broad Institute and Fluidigm Corporation have announced the launch of a new research center dedicated to accelerating the development of research methods and discoveries in mammalian single-cell genomics.

BioMark™ HD SystemThe Single-Cell Genomics Center is also expected to act as a hub for collaboration among single-cell genomics researchers in many pioneering fields, including stem cells and cancer biology. The Center will be housed at the Broad Institute in Cambridge, Massachusetts and will feature a complete suite of Fluidigm single-cell tools, protocols and technologies, most notably the BioMarkTM HD System...

 

  Fluidigm & AH diagnostics Sign Scandinavian Distribution Deal FluidigmFluidigm Corporation has appointed AH diagnostics as its exclusive distributor in Scandinavia (Sweden, Norway, Finland, Denmark, Iceland), effective February 1, 2012. AH diagnostics will offer Fluidigm's complete portfolio of BioMarkTM HD, EP1TM, and Access ArrayTM Systems, the complete line up of Dynamic ArrayTM, Digital ArrayTM and Access Array IFCs for real-time PCR, digital PCR, single-cell gene expression, sample preparation for next-generation sequencing, and SNP genotyping; plus Fluidigm's new DELTAgeneTM and SNPtypeTM assays...

 

  Fluidigm technology used to validate new risk loci for Graves disease Fluidigm technology used to validate new risk loci for Graves diseaseFluidigm Corporation has announced that Rujin Hospital in Shanghai, China has used the company's integrated fluidic circuits (IFCs) to help validate two new susceptibility loci for Graves' disease. Researchers applied the unique properties of the Fluidigm 96.96 Dynamic Array IFC and the EP1 System to re-genotype selected SNPs for the replication study...

 

  Fluidigm & BD Biosciences to Co-Host Single-Cell Seminars FluidigmFluidigm Corporation has announced a collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), to co-host a public seminar series on the isolation and analysis of single cells. Entitled 'A Powerful Technique for Single-Cell Analysis', the public seminar series will showcase cell isolation using the BD FACSAria III Cell Sorter and analysis using the Fluidigm BioMark HD System...

 

  Combining Cell Biology and Molecular Genetics for Single-Cell Research fluidigmFluidigm Corporation has announced a collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), to co-host a public seminar series on the isolation and analysis of single cells. Entitled 'A Powerful Technique for Single-Cell Analysis', the public seminar series will showcase cell isolation using the BD FACSAria III Cell Sorter and analysis using the Fluidigm BioMark HD System.

 

  Fluidigm launch Customer Web Videos Fluidigm launch Customer Web VideosFluidigm has added a new genre - customer web videos to the wide array of topical information (publications, application notes, posters, newsletters, press releases) available from its website. Eve Marquis, Marketing Manager of Fluidigm Europe commented "Online video creates a more personal interaction between Fluidigm and our target audience in Single Cell, Gene Expression, SNP Genotyping, Next Generation Sequencing and Copy Number Variation markets...

 

  Automated Sample Preparation for Targeted Resequencing Access Array™ Fluidigm has announced that the Broad Institute of MIT and Harvard has purchased an Access ArrayTM System to automate its sample preparation for targeted resequencing. The Access Array System enhances the capabilities of powerful next-generation sequencing platforms by allowing the preparation of several sample libraries in parallel...

 

  Fast Dynamic Array IFC for Ag-Bio & Genotyping Studies 192.24 Dynamic Array™ IFCFluidigm Corporation has introduced its 192.24 Dynamic ArrayTM IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour. The 192.24 integrated fluidic circuit (IFC) has immediate applicability in agricultural biotechnology and genome wide association studies...

 

  Fluidigm Launches Low-Cost Assays and Target-Specific Primers Fluidigm Launches Low-Cost Assays and Target-Specific PrimersFluidigm Corporation has announced the availability of new assays and primers optimized for the company's integrated fluidic circuit technology. Fluidigm Assays and Target-specific Primers will provide customers with significantly lower costs than today's standard solutions, at volumes appropriate for microfluidics, and flexible chemistries so that customers can easily create highly multiplexed panels using off-the-shelf and custom content focused on their particular research area. As part of the program, Fluidigm will provide the assay primer locus sequences with every order...

 

  Fluidigm Announces One Billion NanoFlex Valves Shipped NanoFlex™ Valves Fluidigm has announced that its Singapore factory has now manufactured and shipped more than 1 billion microscopic NanoFlexTM valves. Each NanoFlex valve is so small that it takes 10 to span the width of a human hair. The billion valves built into Fluidigm's integrated fluidic circuits (IFCs) are equivalent to the number of valves required for all the conventional plumbing for every home in California, Texas and New York (the three most populous states in the United States of America)...

 

  Human DNA Experiment Uses 200k Digital Array Chip BioMark HD systemFluidigm Europe has announced a new technical report that describes experimentation on a normal human genomic DNA sample using a prototype 200k Digital Array Chip on a modified BioMarkTM System.

 

  Fluidigm Access Array Technology Helps Identify Mutations in Leukemia Fluidigm Access Array TechnologyFluidigm has announced that MLL Munich Leukemia Laboratory (www.mll.com) has used the company's Access ArrayTM technology to help it uncover mutations in over 80 percent of chronic myelomonocytic leukemia (CMML) patients, providing new insights into the molecular heterogeneity of the disease. MLL researchers applied the unique properties of the Fluidigm Access Array System to prepare the samples and barcode the amplicons for next-generation deep-sequencing using 454 sequencing technology...

 

  Fluidigm System Helps Identify Cancer Biomarkers BioMark™ System and Digital Array™ integrated fluidic circuits (IFCsUsing Fluidigm Corporation's BioMarkTM System and Digital ArrayTM integrated fluidic circuits (IFCs), researchers from the University of California San Francisco (UCSF)** have identified serum microRNAs that can serve as biomarkers for prostate cancer...

 

  IMGM Laboratories Adopts Fluidigm Access Array System FluidigmIMGM Laboratories GMBH has purchased a Fluidigm Access ArrayTM System to use in its development and validation of targeted re-sequencing applications services. IMGM is the first Genomic Services Provider to offer the combination of the Fluidigm Access Array technology in conjunction with Roche's 454 Next-Generation Sequencing Systems to its customers in Germany...

 

  Fluidigm Announce Israeli Distribution Deal Fluidigm CorporationFluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Eisenberg Brothers Ltd. as its distributor in Israel. Eisenberg Brothers will offer Fluidigm's complete portfolio of BioMark, EP1, and Access Array Systems and the complete line up of Dynamic Array, Digital Array and Access Array IFCs for real-time PCR, digital PCR, genotyping, gene expression, copy number variation and absolute quantification for sequencing...

 

  Identifying microRNAs that can serve as biomarkers for prostate cancer Fluidigm Corporation's BioMark™ System and Digital Array™ integrated fluidic circuits (IFCs), Using Fluidigm Corporation's BioMarkTM System and Digital ArrayTM integrated fluidic circuits (IFCs), researchers from the University of California San Francisco (UCSF) have identified serum microRNAs that can serve as biomarkers for prostate cancer.

 

  Advanced High Definition Genomic Analysis System BioMark™ HD Real-time PCR SystemFluidigm has introduced the new BioMarkTM HD Real-time PCR System, the company's most advanced instrument for genomic analysis ever. The BioMark HD System is designed for researchers who require the sensitivity and throughput needed to study gene expression down to the single-cell level -- especially those who have limited amounts of sample or study rare populations of cells.

 

  Fluidigm Launches Informative New Website for Biological Researchers Fluidigm Launches Informative New Website for Biological ResearchersFluidigm has launched a new comprehensively featured website designed to offer a wide variety of useful information to life science organisations involved with gene expression, single cell research, SNP genotyping, target resequencing, NGS sample preparation and determination of copy number variation.

 

  A fundamental breakthrough for single-cell gene expression analysis A fundamental breakthrough for single-cell gene expression analysisAvailable from Fluidigm Europe - a recent independent feature in Technology Review Magazine calls Fluidigm's technology "a fundamental breakthrough in how researchers can interact with the biological world".

 

  Leading Leukemia Lab Invests In Fluidigm Access Array and EP1 Systems Fluidigm Access Array™ and EP1™ SystemsFluidigm Corporation has announced that MLL Munich Leukemia Laboratory has purchased Access ArrayTM and EP1TM Systems. The Access Array System is being used in combination with Roche's 454 GS FLX and GS Junior sequencing instruments, enabling high-throughput targeted deep-resequencing analyses. The EP1 System is being used for rare mutation detection studies and minimal residual disease investigations.

 

  Webinar - Exploring Genetic Diversity Exploring Genetic DiversityFluidigm Europe has announced an opportunity for scientists to learn more about how the Fluidigm Access ArrayTM System is being used by the US National Cancer Institute to explore genetic diversity and how to effectively implement techniques for next generation sequencing.

 

  Roche and Fluidigm Corporation Enter Worldwide Co-Promotion Agreement 454 Life Sciences, a Roche Company, and Fluidigm Corporation have announced that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.

 

  Research Newsletter for Biochip User Community Fluidigm Community Newsletter Fluidigm Corporation has announced that the Fall 2010 edition of its community newsletter is now available free to download. The Fluidigm Community Newsletter is a quarterly publication dedicated to providing you with the most recent research, product updates, and news featuring Fluidigm Integrated Fluidic Circuit (IFC) technology

 

  Reusable bio-chip offers ultra-low cost, high sample throughput SNP genotyping Fluidigm Corporation has launched its reusable FR48.48 Dynamic ArrayTM integrated fluidic circuit (IFC) - the world's first reusable bio-chip for the SNP genotyping market. This chip begins a new era of ultra-low cost, high sample throughput SNP genotyping and marks the beginning of Fluidigm's drive toward one-penny-per-data point.

 

  Robust, High-Throughput Verification & Genotyping of Fish Populations A new application poster** from Fluidigm Europe describing how its BioMarkTM System and 96.96 Dynamic ArrayTM Integrated Fluidic Circuit (IFC) has been used by the University of Washington for verification and genotyping of SNP's in Alaskan populations of Chum Salmon.

 

  Easy, Cost Effective Capture & Sequencing of Whole Virus Genome Fluidigm Europe has announced a new technical poster** describing how its unique Access ArrayTM chip technology has been used by the Core Genotyping facility at the National Cancer Institute (Bethesda, MD) to successfully capture and sequence the entire Epstein Barr Virus (EBV) genome from 4 individual patient DNA samples in a single sequence capture run.

 

  Leading Agricultural Institute Reports On Robust Genetic Analysis Results Fluidigm Corporation has announced that the Toulouse Midi-Pyrénées Genomic Platform - Genotoul INRA core facility is now providing a wide range of services on a BioMarkTM System for Genetic Analysis to a diverse range of French researchers.

 

  Modelling The Genetic Circuitry Of Cell-To-Cell Communication Utilizing Fluidigm Corporation's Dynamic ArrayTM and Digital ArrayTM integrated fluidic circuits (IFCs), Stanford University researchers to have discovered a much larger spectrum of differences between individual cells than has previously been demonstrated. Among these differences are the communication capabilities that emerge from the interactions of genetic circuitry that mediates cell-to-cell communication.

 

  Advances In Single-Cell Research The Summer 2010 edition of the popular e-newsletter - IFC Application Hotspot from Fluidigm Corporation is now available free to download

 

  Fluidigm Introduces World's first Reusable Biochip Architecture Fluidigm Corporation has announced it has developed the world's first reusable bio-chip architecture for the commercial market. These reusable integrated fluidic circuits (IFCs) will dramatically lower SNP genotyping costs and are designed to support accelerated sample throughput, while maintaining data quality of 99.75 percent or greater accuracy and 99 percent or greater call rates.

 

  High Sample Throughput SNP Genotyping of Cattle Fluidigm Europe has announced the availability of a new technical poster** describing how the Fluidigm EP1TM System provides the ideal solution for high sample throughput SNP genotyping studies in animals and plants because it offers outstanding data quality and workflow efficiency.

 

  New FC1 Cycler Boosts Productivity While Lowering Costs The new FC1TM Cycler from Fluidigm Corporation is designed to reduce the thermal cycling time by a factor of three when compared with the company's current products. The FC1 Cycler can reduce overall system configuration costs for customers conducting high sample throughput SNP genotyping since they will need fewer thermal cyclers to achieve their output requirements.

 

  Fluidigm Releases New Access Array System Amplicon Tagging Protocol Fluidigm Corporation has announced the release of a new protocol for the Access ArrayTM System that enables sequencing of amplicon libraries using GS FLX Titanium Series reagents on the 454 GS FLX sequencing system. The Access Array integrated fluidic circuit (IFC) automatically generates emPCR-ready libraries by simultaneously combining 48 samples and 48 primer sets to produce 48 uniquely-barcoded samples per chip for approximately 7 Euro per sample.

 

  Single Cell Expression Data Offers Detailed Molecular Understanding Of Embryonic Development Scientists at the Genome Institute of Singapore (GIS)** have recently generated significant single cell expression data crucial for a detailed molecular understanding of mammalian development from fertilization to embryo implantation, a process known as the preimplantation period

 

  Pathway-Focused Gene Expression Panels Validated for Real-time PCR Fluidigm Corporation and SABiosciences (a QIAGEN Company) have announced that they have teamed up to create over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMarkTM System for Genetic Analysis. These kits are named the RT² ProfilerTM PCR Arrays for the Fluidigm BioMark system

 

  Leading European Human Genetics Group Invests In Fluidigm Access Array system Fluidigm Corporation and BIOKÉ, distributor of Fluidigm systems in the Benelux, have announced that Leiden University Medical Center's (LUMC) Human Genetics Department has purchased a Fluidigm Access ArrayTM system. The Access Array system enables users to automatically prepare sequencing-ready libraries from up to 48 individual samples at a time, for as little as €7 (EURO) per sample.

 

  Fluidigm & IntegraGen Join Forces To Create A Genetic Analysis Service And European Demonstartion Facility Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France's leading providers of genetic research testing services, to bring IFC technology to European researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMarkTM System for Genetic Analysis and the Access ArrayTM sample preparation system for next-generation sequencing

 

  Development and Validation Testing of Cattle SNP Panels Fluidigm Corporation has announced that the U.S. Department of Agriculture's Agricultural Research Service (ARS) has purchased a Fluidigm microfluidic-based EP1TM System to help develop and validate focused 96- and 384-SNP (single-nucleotide polymorphism) panels for testing America's dairy and beef cattle.

 

  Fluidigm Corporation & OncoMed Pharmaceuticals, Inc. Announce Strategic Collaboration OncoMed Pharmaceuticals, Inc. and Fluidigm Corporation have announced a new initiative to apply Fluidigm's unique microfluidic tools to the analysis of tumor cell heterogeneity, including cancer stem cells.

 

  Fluidigm BioMark System Sales Surpass The Century Mark Fluidigm Corporation has announced that sales of its flagship BioMark™ System for Genetic Analysis have now surpassed 100 cumulative units in the field. The BioMark system, based on proprietary microfluidic chips called integrated fluidic circuits (IFCs), provides high throughput real-time qPCR enabling researchers to streamline their experimental workflow, increase throughput and lower costs.